Previous close | 539.57 |
Open | 542.20 |
Bid | 539.98 x 100 |
Ask | 541.36 x 100 |
Day's range | 537.39 - 543.28 |
52-week range | 372.50 - 583.39 |
Volume | |
Avg. volume | 428,329 |
Market cap | 44.862B |
Beta (5Y monthly) | 1.27 |
PE ratio (TTM) | 53.78 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WESTBROOK, Maine, February 20, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences:
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of Vello, a software solution that seamlessly connects veterinary practices and clients through modern, digital tools. As the only pet owner engagement solution purpose-built for IDEXX practice management software, Vello enables veterinary practices using ezyVet®, Neo®, and Cornerstone® software to communicate efficiently with pet owners in a single, easy-to-use system. With software-suppo
WESTBROOK, Maine, February 05, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results.